279 related articles for article (PubMed ID: 33297444)
1. Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus.
Alavi M; Asare-Addo K; Nokhodchi A
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33297444
[TBL] [Abstract][Full Text] [Related]
2. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
[TBL] [Abstract][Full Text] [Related]
3. Microformulations and Nanoformulations of Doxorubicin for Improvement of Its Therapeutic Efficiency.
Alavi M; Nokhodchi A
Crit Rev Ther Drug Carrier Syst; 2020; 37(6):591-611. PubMed ID: 33426834
[TBL] [Abstract][Full Text] [Related]
4. Sensing specific adhesion of liposomal and micellar systems with attached carbohydrate recognition structures at lectin surfaces.
Hildebrand A; Schaedlich A; Rothe U; Neubert RH
J Colloid Interface Sci; 2002 May; 249(2):274-81. PubMed ID: 16290597
[TBL] [Abstract][Full Text] [Related]
5. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
Barre A; Van Damme EJM; Simplicien M; Le Poder S; Klonjkowski B; Benoist H; Peyrade D; Rougé P
Cells; 2021 Jun; 10(7):. PubMed ID: 34203435
[TBL] [Abstract][Full Text] [Related]
6. Lectins and lectibodies: potential promising antiviral agents.
Nabi-Afjadi M; Heydari M; Zalpoor H; Arman I; Sadoughi A; Sahami P; Aghazadeh S
Cell Mol Biol Lett; 2022 May; 27(1):37. PubMed ID: 35562647
[TBL] [Abstract][Full Text] [Related]
7. Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections.
Wang DY; van der Mei HC; Ren Y; Busscher HJ; Shi L
Front Chem; 2019; 7():872. PubMed ID: 31998680
[TBL] [Abstract][Full Text] [Related]
8. Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges.
Alavi M; Nokhodchi A
Drug Discov Today; 2022 Feb; 27(2):576-584. PubMed ID: 34688912
[TBL] [Abstract][Full Text] [Related]
9. Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells.
Brück A; Abu-Dahab R; Borchard G; Schäfer UF; Lehr CM
J Drug Target; 2001; 9(4):241-51. PubMed ID: 11697028
[TBL] [Abstract][Full Text] [Related]
10. Lectins Are the Sparkle of Hope for Combating Coronaviruses and the Global COVID-19.
Abbas HS; Kotakonda M
Adv Pharm Bull; 2022 Mar; 12(2):319-328. PubMed ID: 35620331
[TBL] [Abstract][Full Text] [Related]
11. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
12. The Use of Lectins as Tools to Combat SARS-CoV-2.
Martinez D; Amaral D; Markovitz D; Pinto L
Curr Pharm Des; 2021; 27(41):4212-4222. PubMed ID: 34459375
[TBL] [Abstract][Full Text] [Related]
13. Lectin-Carbohydrate Interactions: Implications for the Development of New Anticancer Agents.
de Oliveira Figueiroa E; Albuquerque da Cunha CR; Albuquerque PBS; de Paula RA; Aranda-Souza MA; Alves MS; Zagmignan A; Carneiro-da-Cunha MG; Nascimento da Silva LC; Dos Santos Correia MT
Curr Med Chem; 2017 Nov; 24(34):3667-3680. PubMed ID: 28545372
[TBL] [Abstract][Full Text] [Related]
14. Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.
Omrani M; Keshavarz M; Nejad Ebrahimi S; Mehrabi M; McGaw LJ; Ali Abdalla M; Mehrbod P
Front Pharmacol; 2020; 11():586993. PubMed ID: 33679384
[TBL] [Abstract][Full Text] [Related]
15. Platensimycin-Encapsulated Liposomes or Micelles as Biosafe Nanoantibiotics Exhibited Strong Antibacterial Activities against Methicillin-Resistant
Wang Z; Liu X; Peng Y; Su M; Zhu S; Pan J; Shen B; Duan Y; Huang Y
Mol Pharm; 2020 Jul; 17(7):2451-2462. PubMed ID: 32519867
[TBL] [Abstract][Full Text] [Related]
16. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
Abd El-Aziz TM; Stockand JD
Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
[TBL] [Abstract][Full Text] [Related]
17. Lectins from plants and algae act as anti-viral against HIV, influenza and coronaviruses.
Naik S; Kumar S
Mol Biol Rep; 2022 Dec; 49(12):12239-12246. PubMed ID: 36138301
[TBL] [Abstract][Full Text] [Related]
18. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion.
Abu-Dahab R; Schäfer UF; Lehr CM
Eur J Pharm Sci; 2001 Aug; 14(1):37-46. PubMed ID: 11457648
[TBL] [Abstract][Full Text] [Related]
19. Applications of mannose-binding lectins and mannan glycoconjugates in nanomedicine.
Gupta A; Gupta GS
J Nanopart Res; 2022; 24(11):228. PubMed ID: 36373057
[TBL] [Abstract][Full Text] [Related]
20. Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications.
Coelho LC; Silva PM; Lima VL; Pontual EV; Paiva PM; Napoleão TH; Correia MT
Evid Based Complement Alternat Med; 2017; 2017():1594074. PubMed ID: 28367220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
